Thursday, 10 October 2013

A new two-part Lancet Series on stem cells outlines exciting new advances in the treatment of multiple sclerosis

Source The Lancet:
A new two-part Lancet Series on stem cells outlines exciting new advances in the treatment of multiple sclerosis and severe epidermolysis bullosa, a rare but devastating genetic skin disease. In the first Series paper, Professor Neil Scolding and colleagues, outline the latest challenges and exciting potential for stem cell treatment of multiple sclerosis.  For more click here (please note there is an audio link on the bottom right of the screen where Prof Neil Scolding discusses the future role of stem-cell therapies for multiple sclerosis)